Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, June 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 57 Mendeley

Summary Policy documents X Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review

Article in Frontiers in Endocrinology (December 2023)

Canagliflozin + metformin ER for the treatment of type 2 diabetes: the evidence to date

Article in Expert Opinion on Pharmacotherapy (November 2023)

Development of LC-MS/MS method for simultaneous determination of Canagliflozin and Metformin in human plasma and its pharmacokinetic application in Indian population under fast and fed conditions

Article in Journal of Chromatography B (July 2020)